Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00407043 · ClinicalTrials.gov registry record · Phase 4
Multicenter, Randomized, Controlled Study of the Effect of Lotemax on Initiation of Dry Eye Treatment With Restasis
A Phase 4 study, sponsored by Ophthalmic Consultants of Long Island.
- Completed
- Registry status
- Phase 4
- Development phase
- 5
- Enrollment target
NCT00407043: Completed Phase 4 study, sponsored by Ophthalmic Consultants of Long Island.
NCT00407043 is a Phase 4 study that has completed, run by Ophthalmic Consultants of Long Island. The registered enrollment target is 5 participants, below the 518-participant average among 9,235 other Phase 4 trials with a reported enrollment target (99% lower). According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00407043, a Phase 4 study, has completed, sponsored by Ophthalmic Consultants of Long Island.
- COMPLETED
- Registry status
- Phase 4
- Development phase
- 5 participants
- Enrollment target
Study Summary
To evaluate the impact of Lotemax on the initiation of Restasis therapy in patients with dry eye. It is hypothesized that the anti-inflammatory activity of Lotemax may help mitigate the stinging with cyclosporine administration and the dry eye signs and symptoms experienced during the initiation of therapy.
Interventions
- DRUG Restasis
- DRUG Lotemax
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 5 participants |
| Start Date | 2006-11 |
| Est. Completion | 2007-09 |
| Phase | Phase 4 |
What the finished NCT00407043 record still lists
NCT00407043 is an interventional study that assigns participants to a tested intervention. The registry caps enrollment at 5 participants, a relatively small participant target, below the 518-participant average among 9,235 other Phase 4 trials with a reported enrollment target (99% lower).
The record links to 0 conditions, and to 2 interventions - of which Restasis is the first listed.
NCT00407043 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00407043 about?
NCT00407043 is a clinical study titled "Multicenter, Randomized, Controlled Study of the Effect of Lotemax on Initiation of Dry Eye Treatment With Restasis". To evaluate the impact of Lotemax on the initiation of Restasis therapy in patients with dry eye. It is hypothesized that the anti-inflammatory activity of Lotemax may help mitigate the stinging with cyclosporine administration and the dry eye signs and symptoms experienced during the initiation of...
What is the current status of trial NCT00407043?
This trial is currently completed. It is a Phase 4 study. The enrollment target is 5 participants. The study started on 2006-11. Estimated completion is 2007-09.
What interventions are being tested in trial NCT00407043?
The interventions under investigation include: Restasis (DRUG), Lotemax (DRUG).
Who is sponsoring clinical trial NCT00407043?
This trial is sponsored by Ophthalmic Consultants of Long Island, which has 6 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
How this trial's enrollment target compares
Where NCT00407043's enrollment target sits among peer trials
5 1989th of 2000 higher than 7 of 2,000 other Phase 4 trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Phase 4 trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia